Akihiro Honda

988 total citations
56 papers, 662 citations indexed

About

Akihiro Honda is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Akihiro Honda has authored 56 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 22 papers in Pulmonary and Respiratory Medicine and 19 papers in Epidemiology. Recurrent topics in Akihiro Honda's work include Peroxisome Proliferator-Activated Receptors (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cardiovascular Function and Risk Factors (6 papers). Akihiro Honda is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cardiovascular Function and Risk Factors (6 papers). Akihiro Honda collaborates with scholars based in Japan and United States. Akihiro Honda's co-authors include Nobuhiro Tahara, Atsuko Tahara, Shotaro Kamata, Sho‐ichi Yamagishi, Isao Ishii, Yoshihiro Fukumoto, Yoshikazu Nitta, Hayato Kaida, Norihiro Kodama and Sachiyo Igata and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Akihiro Honda

47 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihiro Honda Japan 14 187 172 171 161 151 56 662
Samy Hadjadj France 16 196 1.0× 208 1.2× 177 1.0× 172 1.1× 224 1.5× 32 808
Zengchun Ye China 21 437 2.3× 153 0.9× 311 1.8× 100 0.6× 80 0.5× 47 1.2k
Mitsuo Tanimoto Japan 20 222 1.2× 129 0.8× 198 1.2× 180 1.1× 251 1.7× 45 1.1k
Zhi Guo China 12 175 0.9× 95 0.6× 182 1.1× 158 1.0× 144 1.0× 24 874
Zhilian Li China 20 381 2.0× 176 1.0× 169 1.0× 87 0.5× 55 0.4× 64 1.0k
Jianmin Ran China 14 182 1.0× 234 1.4× 175 1.0× 148 0.9× 244 1.6× 41 795
Maki Murakoshi Japan 18 218 1.2× 108 0.6× 118 0.7× 135 0.8× 223 1.5× 55 905
Srikanth Koneru United States 14 378 2.0× 114 0.7× 273 1.6× 218 1.4× 77 0.5× 28 989
Zuhal Parıldar Türkiye 14 116 0.6× 65 0.4× 104 0.6× 101 0.6× 89 0.6× 32 569
Nobuhiko Togashi Japan 13 173 0.9× 191 1.1× 196 1.1× 222 1.4× 165 1.1× 17 647

Countries citing papers authored by Akihiro Honda

Since Specialization
Citations

This map shows the geographic impact of Akihiro Honda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Honda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Honda more than expected).

Fields of papers citing papers by Akihiro Honda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Honda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Honda. The network helps show where Akihiro Honda may publish in the future.

Co-authorship network of co-authors of Akihiro Honda

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Honda. A scholar is included among the top collaborators of Akihiro Honda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Honda. Akihiro Honda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tahara, Atsuko, Nobuhiro Tahara, Akihiro Honda, et al.. (2025). Clinical and biochemical factors associated with amygdalar metabolic activity. PubMed. 11(1). 2–2.
2.
3.
4.
Kamata, Shotaro, Akihiro Honda, & Isao Ishii. (2023). Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease. Biomolecules. 13(8). 1264–1264. 35 indexed citations
5.
Tahara, Nobuhiro, et al.. (2023). Compression Stockings Improve Lower Legs Symptom in Patients with Pulmonary Artery Hypertension Treated by Pulmonary Vasodilators—A Pilot Study. Journal of Clinical Medicine. 12(7). 2484–2484. 2 indexed citations
6.
7.
Kitai, Takeshi, Kentaro Iwata, Takayuki Shimogai, et al.. (2023). Predictive factors and clinical impact of ICU-acquired weakness on functional disability in mechanically ventilated patients with COVID-19. Heart & Lung. 60. 139–145. 9 indexed citations
8.
Takaseya, Tohru, Ken‐ichiro Sasaki, Masahiro Sasaki, et al.. (2023). Cusp overlap technique decreases paravalvular leakage in self-expandable transcatheter aortic valve replacement. Heart and Vessels. 39(1). 48–56. 1 indexed citations
9.
Honda, Akihiro, et al.. (2022). Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate. International Journal of Molecular Sciences. 23(9). 4726–4726. 20 indexed citations
10.
Suda, Kenji, Nobuhiro Tahara, Akihiro Honda, et al.. (2022). Ongoing vascular inflammation evaluated by 18F-fluorodeoxyglucose positron emission tomography in patients long after Kawasaki disease. Journal of Nuclear Cardiology. 30(1). 264–275. 2 indexed citations
11.
Kawaguchi, Takumi, Akihiro Honda, Yoichi Sugiyama, et al.. (2021). Association between the albumin–bilirubin (ALBI) score and severity of portopulmonary hypertension (PoPH): A data‐mining analysis. Hepatology Research. 51(12). 1207–1218. 13 indexed citations
12.
Honda, Akihiro, et al.. (2021). Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist. Biological and Pharmaceutical Bulletin. 44(9). 1210–1219. 14 indexed citations
13.
Honda, Akihiro, Takahiro Shojima, Nobuhiro Tahara, et al.. (2020). Life-threatening huge right atrial diverticulum. European Heart Journal - Case Reports. 4(5). 1–2. 2 indexed citations
14.
Kamata, Shotaro, Takuji Oyama, Kenta Saito, et al.. (2020). PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates. iScience. 23(11). 101727–101727. 59 indexed citations
15.
Akahoshi, Noriyuki, Masashi Miyashita, Chihiro Saito, et al.. (2020). Increased Urinary 3-Mercaptolactate Excretion and Enhanced Passive Systemic Anaphylaxis in Mice Lacking Mercaptopyruvate Sulfurtransferase, a Model of Mercaptolactate-Cysteine Disulfiduria. International Journal of Molecular Sciences. 21(3). 818–818. 13 indexed citations
16.
Kamata, Shotaro, Ryota Saito, Akihiro Honda, et al.. (2020). Cytotoxicity comparison of 35 developmental neurotoxicants in human induced pluripotent stem cells (iPSC), iPSC-derived neural progenitor cells, and transformed cell lines. Toxicology in Vitro. 69. 104999–104999. 9 indexed citations
17.
Tahara, Nobuhiro, Yoshikazu Nitta, Atsuko Tahara, et al.. (2019). Two-hour postload plasma glucose and pigment epithelium-derived factor levels are markers of coronary artery inflammation in type 2 diabetic patients. Journal of Nuclear Cardiology. 27(4). 1352–1364. 5 indexed citations
18.
19.
Koiwaya, Hiroshi, Nobuhiro Tahara, Atsuko Tahara, et al.. (2016). In Vivo Molecular Imaging of Ruptured Coronary Atherosclerotic Plaque Using IVUS, OCT, and FDG-PET/CT. JACC: Cardiovascular Interventions. 9(12). e113–e115. 2 indexed citations
20.
Tahara, Nobuhiro, Atsuko Tahara, Akihiro Honda, et al.. (2016). FDG-PET/CT images during 5 years before acute aortic dissection. European Heart Journal. 37(24). 1933–1933. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samy Hadjadj Breakdown of academic impact, for papers by Zengchun Ye Breakdown of academic impact, for papers by Mitsuo Tanimoto Breakdown of academic impact, for papers by Zhi Guo Breakdown of academic impact, for papers by Zhilian Li Breakdown of academic impact, for papers by Jianmin Ran Breakdown of academic impact, for papers by Maki Murakoshi Breakdown of academic impact, for papers by Srikanth Koneru Breakdown of academic impact, for papers by Zuhal Parıldar Breakdown of academic impact, for papers by Nobuhiko Togashi
Rankless by CCL
2026